US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), INSTITUT REGIONAL DU CANCER DE MONTPELLIER, UNIVERSITE DE MONTPELLIER on March 17 for "Antibodies having specificity to HER4 and uses thereof" (French Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,324, issued on March 17, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), INSTITUT REGIONAL DU CANCER DE MONTPELLIER (Montpellier, France) and UNIVERSITE DE MONTPELLIER (Montpellier, France).

"Antibodies having specificity to HER4 and uses thereof" was invented by Andre Pelegrin (Montpellier Cedex, France), Pierre Martineau (Montpellier Cedex, France), Thierry Chardes (Montpellier Cedex, France) and Romain Lanotte (Calvisson, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies having specificity to HER4 and uses thereof, which are able to induce biased 4ICD rou...